Back
Speaker illustration

Mrs Saga Itainen-Stromberg

Helsinki University Hospital, Helsinki (Finland)

Member of:

European Society of Cardiology
European Heart Rythm Association

Presentations Articles

How much does elective cardioversion increase the risk of ischaemic stroke compared to the baseline risk in atrial fibrillation? A nationwide study.

Event: ESC Congress 2024

Topic: Rhythm Control, Cardioversion

Session: Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians

Access
Like
Thumbnail

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Event: ESC Congress 2022

Topic: Rhythm Control, Cardioversion

Session: Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Access
Like
Thumbnail

Oral anticoagulation in patients undergoing elective cardioversion of atrial fibrillation. Real-life experience from Finland

Event: ESC Congress 2019

Topic: Rhythm Control, Cardioversion

Session: Drug treatment for atrial fibrillation

Access
Like
Thumbnail

Direct oral anticoagulants in atrial fibrillation patients undergoing cardioversion. Nationwide multicentre study.

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: New trends in antithrombotic therapy for atrial fibrillation

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources